Clinical Trials on Multiple Sclerosis in United Kingdom
Total 5154 results
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
Sheikh Shakhbout Medical CityRecruitingSpasticity, Muscle | Oxygen Consumption | Sclerosis, Multiple | Spastic | MS (Multiple Sclerosis)United Arab Emirates
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
Massachusetts General HospitalGilead SciencesWithdrawnFatigue | Multiple Sclerosis, Relapsing-RemittingUnited States
-
TG Therapeutics, Inc.RecruitingA Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk (PROVIDE)Relapsing Multiple SclerosisUnited States
-
University of California, San DiegoCompletedMultiple Sclerosis (MS)United States
-
Genentech, Inc.Roche Pharma AGCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada, Belgium, Spain, France, Switzerland, Ukraine, Mexico, Germany, Bulgaria, United Kingdom, Romania, Czechia, Italy, Russian Federation, Serbia, Slovakia, Denmark
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
Immune Response BioPharma, Inc.Not yet recruitingMultiple SclerosisUnited States
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
City University of New YorkRecruitingMultiple Sclerosis,Gait, ExerciseUnited States
-
Wayne State UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Johns Hopkins UniversityGenentech, Inc.Active, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Providence Health & ServicesMicrostein, LLCCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Rush University Medical CenterCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
Nelson Mandela Metropolitan UniversityUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
VA Office of Research and DevelopmentOregon Health and Science UniversityCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
University of VermontCompletedFatigue | Sleep Initiation and Maintenance Disorders | Relapsing Remitting Multiple SclerosisUnited States
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
University of WashingtonRecruitingFatigue | Multiple Sclerosis (MS) | Physical InactivityUnited States
-
Scripps HealthWithdrawnMultiple Sclerosis, Relapsing-RemittingUnited States
-
Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Clinically Isolated Syndrome | Multiple Sclerosis, Relapsing-Remitting | Healthy Aging | Neurologic Disorder | Neuromyelitis Optica Spectrum Disorders | Radiologically Isolated Syndrome | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Neurologic... and other conditionsUnited States
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)United States, Belgium, Taiwan, Italy, Germany, Canada, Estonia, Mexico, Croatia, Slovakia, Turkey, India, Spain, Argentina, France, Israel, Australia, Austria, Serbia, Brazil, Guatemala, Latvia, Poland, Portugal, Russian Federation, Romania and more
-
University College, LondonCompletedMultiple Sclerosis | Overactive BladderUnited Kingdom
-
Washington University School of MedicineEMD SeronoActive, not recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
University of California, San FranciscoGenentech, Inc.; Valhalla FoundationActive, not recruitingClinically Isolated Syndrome | Relapsing Multiple SclerosisUnited States
-
Cardiff UniversityNovartisUnknownTuberous SclerosisUnited Kingdom
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Washington University School of MedicineBiogenWithdrawnMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
UMC UtrechtBoehringer Ingelheim; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsRecruitingSystemic Sclerosis | Scleroderma, Diffuse | Mycophenolate Mofetil | Scleroderma | Autologous Stem Cell Transplantation | Cyclophosphamide | Systemic Scleroses, Diffuse | Treatment StrategyItaly, Switzerland, Netherlands, Sweden, United Kingdom
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple SclerosisUnited States, Korea, Republic of, India, Brazil, Poland, Canada, Bulgaria, United Kingdom, France, Greece, Italy, Russian Federation, Turkey, Mexico, Austria, Denmark, Guatemala
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Poland, Austria, Belgium, Czechia, Germany, Australia, Switzerland, Lebanon, Argentina, Canada, Slovenia, Bulgaria, Latvia, Russian Federation, Spain, Italy, Turkey, Slovakia, Portugal, Greece, Saudi Arabia, Hungary, No... and more
-
East Kent Hospitals University NHS Foundation TrustCompletedCerebral Stroke | Chronic Brain Injury | MS (Multiple Sclerosis)United Kingdom
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
The Cleveland ClinicNational Institutes of Health (NIH)WithdrawnGait Disturbance in Multiple Sclerosis PatientsUnited States
-
Bristol-Myers SquibbActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisAustralia, United States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteCompletedFatigue in Multiple SclerosisUnited States
-
University of Southern CaliforniaTeva Pharmaceuticals USACompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jazz PharmaceuticalsTerminatedSpasticity With Multiple SclerosisSpain, United States, United Kingdom, Czechia, Poland